Ouro-seq: Improved Recovery of Full-Length circRNAs from Samples with Limited RNA Content

Circular RNAs, or circRNAs, are a new type of RNA with potential as biomarkers, but their detection in liquid biopsy samples is difficult due to their small quantities. To address this issue, researchers created Ouro-seq, a new sequencing method specifically designed to recover full-length circRNAs. The protocol was tested on urine samples from cervical cancer patients, cervico-vaginal self-samples from cervical cancer patients, and plasma samples from lung cancer patients and healthy controls.

The results showed that Ouro-seq recovered 2-5 times more circRNA molecules than existing methods and produced significantly longer sequences.

The samples from plasma were mostly made up of exonic circRNAs, whereas the urine and cervico-vaginal samples were rich in intergenic circRNAs, which were previously not well understood. The study also discovered a variety of alternative circularization and splicing events. Functional analysis revealed that exonic circRNAs had a higher ability to interact with microRNAs (miRNAs), while circRNAs from unplaced regions of the genome had a greater capacity to code for peptides.

These findings demonstrate that Ouro-seq is a valuable tool for characterizing circRNAs in low-yield clinical samples and contributes to our understanding of circRNA biology. The research opens up possibilities for discovering new biomarkers and monitoring disease progression.